GMP細胞治療耗材市場規模、佔有率和成長分析：按產品、細胞治療類型、製程階段、最終用途產業和地區分類－產業預測，2026-2033年

2024 年全球 GMP 細胞治療耗材市場價值為 1,505 萬美元，預計到 2033 年將從 2025 年的 1,940 萬美元成長至 1.4785 億美元，在預測期（2026-2033 年）內複合年成長率為 28.9%。

全球GMP細胞治療耗材市場呈現對符合無菌規範的產品需求不斷成長的趨勢，這些產品旨在支持臨床批准的細胞療法的生產，包括培養基、支架和冷凍保存技術。這個市場的主要驅動力是CAR-T療法、幹細胞療法和基因編輯療法的蓬勃發展，在這些療法中，受控環境對於確保患者安全和產品療效至關重要。隨著監管標準的日益嚴格，市場正轉向使用GMP認證的耗材，迫使企業據此調整其生產能力。此外，同種異體現成產品的興起也推動了創新，因為這些產品需要擴充性的生物製程解決方案和檢驗的冷凍保存技術。隨著製造商逐漸減少自體療法的應用，人們越來越關注可重複性和效率，促進了產品的普及和整體市場成長。

全球GMP細胞治療耗材市場成長要素

細胞療法在各個治療領域的日益普及，促使醫院和研究機構加強對GMP級耗材的投入，從而形成了穩定的市場需求。臨床醫生認知到這些療法在改善患者預後方面的潛在益處，這推動了他們積極參與臨床試驗和商業化過程。臨床實踐中日益成長的興趣加快了採購週期，迫使製造商拓展產品線並強化供應鏈能力。因此，市場持續自然成長，相關人員優先採購可靠、高品質的耗材，這些耗材對於個人化醫療相關的複雜生產流程至關重要。此外，這些趨勢也加速了旨在檢驗先進耗材有效性的合作研究。

全球GMP細胞治療耗材市場的限制因素

全球GMP細胞治療耗材市場面臨嚴峻挑戰，這主要歸因於嚴格的法規結構，該框架要求對生產過程進行全面的檢驗和文件記錄。這些嚴格的標準延長了產品開發週期，迫使企業投入大量資源以確保符合不斷變化的安全性和有效性要求。不同地區對監管規定的解讀差異進一步加劇了合規策略的複雜性，並導致投資決策的猶豫不決。這些嚴格的要求構成了市場准入壁壘，並阻礙了整體成長。對於中小企業而言，競爭尤其激烈，因為它們難以應對成功商業化所需的複雜核准流程。

全球GMP細胞治療耗材市場趨勢

全球GMP細胞治療耗材市場正呈現顯著的體驗式創新趨勢，製造商將即時分析和封閉回路型監測技術融入細胞處理試劑盒中。這項進步使臨床醫生能夠根據生物回饋立即調整治療方案，從而提高細胞療法的個人化和療效。將感測器技術和先進軟體整合到無菌容器中，不僅可以最大限度地減少變異性，還能縮短患者用藥時間，滿足日益成長的個人化治療方案需求。隨著醫院在整個生產過程中更加重視產品完整性和簡化文件記錄，採用這些創新技術的供應商將更有利於在轉向基於價值的報銷模式的市場中獲得競爭優勢。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球GMP細胞治療耗材市場規模：依產品分類。

• 成套工具
• 試劑
• 生長因子
• 白細胞介素
• 其他

全球符合GMP標準的細胞治療耗材市場規模：依細胞治療類型分類

• T細胞療法
• NK細胞療法
• 幹細胞療法
• 其他

全球符合GMP標準的細胞治療耗材市場規模：依製程階段分類

• 細胞收集
• 特徵評估與選擇
• 細胞培養和增殖
• 其他

全球符合GMP標準的細胞治療耗材市場規模：依最終用途產業分類

• 臨床應用
• 商業生產
• 研究領域

全球符合GMP標準的細胞治療耗材市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific Inc
• Danaher Corporation
• Cytiva
• Merck KGaA
• MilliporeSigma
• Sartorius AG
• Lonza Group AG
• Corning Incorporated
• Becton Dickinson and Company
• Bio-Rad Laboratories Inc
• Miltenyi Biotec BV & Co KG
• Terumo Blood and Cell Technologies
• Fresenius Kabi AG
• Repligen Corporation
• Entegris Inc
• Saint-Gobain Life Sciences
• Corning Life Sciences
• STEMCELL Technologies Inc
• PromoCell GmbH
• FUJIFILM Irvine Scientific Inc

結論與建議

Global GMP Cell Therapy Consumables Market size was valued at USD 15.05 Million in 2024 and is poised to grow from USD 19.4 Million in 2025 to USD 147.85 Million by 2033, growing at a CAGR of 28.9% during the forecast period (2026-2033).

The global GMP cell therapy consumables market is characterized by the increasing demand for sterile and compliant products that support the manufacturing of clinically approved cellular therapies, including culture media, scaffolds, and cryopreservation agents. This market is primarily driven by the surge in CAR-T, stem cell, and gene-edited therapies, which necessitate controlled environments for patient safety and product efficacy. A shift towards GMP-qualified consumables has emerged due to enhanced regulatory standards, pushing companies to adapt their production capabilities accordingly. Moreover, the rise of allogeneic off-the-shelf products calls for scalable bioprocessing solutions and validated cryopreservation technologies, further driving innovation. As manufacturers transition from autologous treatments, the focus on reproducibility and efficiency enhances product adoption and overall market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global GMP Cell Therapy Consumables market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global GMP Cell Therapy Consumables Market Segments Analysis

Global GMP cell therapy consumables market is segmented by product, cell therapy type, process phase, end use industry and region. Based on product, the market is segmented into Kits, Reagents, Growth Factors, Interleukins and Others. Based on cell therapy type, the market is segmented into T Cell Therapy, NK Cell Therapy, Stem Cell Therapy and Others. Based on process phase, the market is segmented into Cell Collection, Characterization Sorting, Cell Culture Expansion and Others. Based on end use industry, the market is segmented into Clinical Applications, Commercial Manufacturing and Research Sector. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global GMP Cell Therapy Consumables Market

The rising acceptance of cell therapies in various therapeutic areas is prompting hospitals and research institutions to invest in GMP-grade consumables, leading to a steady demand in the market. Clinicians are acknowledging the potential benefits of these therapies in improving patient outcomes, which encourages greater participation in clinical trials and commercialization efforts. This increased clinical enthusiasm drives procurement cycles, compelling manufacturers to broaden their product offerings and strengthen their supply chain capabilities. As a result, the market continues to expand organically, with stakeholders prioritizing the acquisition of reliable, high-quality consumables essential for the intricate manufacturing processes associated with personalized treatments. Furthermore, these trends encourage collaborative research aimed at validating advanced consumables.

Restraints in the Global GMP Cell Therapy Consumables Market

The Global GMP Cell Therapy Consumables market faces significant challenges due to stringent regulatory frameworks that dictate comprehensive validation and documentation processes for manufacturing. These rigorous standards extend the product development timelines, forcing companies to dedicate considerable resources to ensure adherence to constantly evolving safety and efficacy requirements. The varying regulatory interpretations across different regions add further complexity to compliance strategies, leading to hesitancy in investment decisions. Such demanding requirements create barriers to market entry, inhibiting overall growth and making it particularly difficult for smaller firms to compete, as they struggle to navigate the intricate approval landscapes necessary for successful commercialization.

Market Trends of the Global GMP Cell Therapy Consumables Market

The Global GMP Cell Therapy Consumables market is witnessing a significant trend towards experiential innovations, as manufacturers incorporate real-time analytics and closed-loop monitoring into cell processing kits. This advancement allows clinicians to make immediate adjustments based on biological feedback, thus enhancing the customization and effectiveness of cell therapies. The integration of sensor technologies and sophisticated software into sterile containers not only minimizes variability but also expedites the time-to-patient, addressing the growing demand for personalized treatment protocols. As hospitals prioritize product integrity and streamlined documentation throughout manufacturing processes, suppliers who embrace these innovations are positioned to capture a competitive advantage in a market increasingly aligned with value-based reimbursement models.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global GMP Cell Therapy Consumables Market Size by Product & CAGR (2026-2033)

• Market Overview
• Kits
• Reagents
• Growth Factors
• Interleukins
• Others

Global GMP Cell Therapy Consumables Market Size by Cell Therapy Type & CAGR (2026-2033)

• Market Overview
• T Cell Therapy
• NK Cell Therapy
• Stem Cell Therapy
• Others

Global GMP Cell Therapy Consumables Market Size by Process Phase & CAGR (2026-2033)

• Market Overview
• Cell Collection
• Characterization Sorting
• Cell Culture Expansion
• Others

Global GMP Cell Therapy Consumables Market Size by End Use Industry & CAGR (2026-2033)

• Market Overview
• Clinical Applications
• Commercial Manufacturing
• Research Sector

Global GMP Cell Therapy Consumables Market Size & CAGR (2026-2033)

• North America (Product, Cell Therapy Type, Process Phase, End Use Industry)
  • US
  • Canada
• Europe (Product, Cell Therapy Type, Process Phase, End Use Industry)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Cell Therapy Type, Process Phase, End Use Industry)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Cell Therapy Type, Process Phase, End Use Industry)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Cell Therapy Type, Process Phase, End Use Industry)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytiva
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MilliporeSigma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec B V & Co KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Blood and Cell Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Entegris Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Saint-Gobain Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PromoCell GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Irvine Scientific Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations